Transcend Capital Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,250
| Closed | -$231K | – | 496 |
|
|
2022
Q2 | $231K | Sell |
4,250
-428
| -9% | -$23.3K | 0.02% | 423 |
|
|
2022
Q1 | $255K | Buy |
4,678
+296
| +7% | +$16.1K | 0.02% | 425 |
|
|
2021
Q4 | $242K | Sell |
4,382
-1,008
| -19% | -$55.7K | 0.02% | 418 |
|
|
2021
Q3 | $271K | Sell |
5,390
-836
| -13% | -$42K | 0.02% | 396 |
|
|
2021
Q2 | $311K | Sell |
6,226
-73
| -1% | -$3.65K | 0.04% | 253 |
|
|
2021
Q1 | $280K | Buy |
6,299
+5
| +0.1% | +$222 | 0.03% | 322 |
|
|
2020
Q4 | $290K | Sell |
6,294
-1,129
| -15% | -$52K | 0.04% | 299 |
|
|
2020
Q3 | $349K | Buy |
+7,423
| New | +$349K | 0.06% | 200 |
|
|
2020
Q2 | – | Sell |
-7,438
| Closed | -$352K | – | 148 |
|
|
2020
Q1 | $352K | Sell |
7,438
-236
| -3% | -$11.2K | 0.11% | 162 |
|
|
2019
Q4 | $451K | Buy |
+7,674
| New | +$451K | 0.12% | 148 |
|